Faron Pharmaceuticals Oy (LON:FARN – Get Free Report)’s share price passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 203.53 ($2.62) and traded as low as GBX 155.75 ($2.00). Faron Pharmaceuticals Oy shares last traded at GBX 162.50 ($2.09), with a volume of 8,437 shares trading hands.
Faron Pharmaceuticals Oy Trading Down 4.6 %
The business’s 50-day simple moving average is GBX 203.53 and its 200-day simple moving average is GBX 169.61. The company has a market cap of £162.16 million, a PE ratio of -507.81 and a beta of 0.36. The company has a current ratio of 1.45, a quick ratio of 1.09 and a debt-to-equity ratio of 922.55.
Faron Pharmaceuticals Oy Company Profile
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company’s lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.
Featured Stories
- Five stocks we like better than Faron Pharmaceuticals Oy
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- What is Insider Trading? What You Can Learn from Insider Trading
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.